THE HARPLE GROUP, LLC

Lobbying for GRAIL, INC. · Biotechnology Company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $30,000.00 income · posted Oct 9, 2025

Lobbying activity 1

Health Issues

Issues related to oncology and early multi-cancer detection, including diagnostics and screening.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.